Skip to main navigation Skip to search Skip to main content

The epidemiology of anaphylaxis in Europe: A systematic review

  • S. S. Panesar
  • , S. Javad
  • , D. De Silva
  • , B. I. Nwaru
  • , L. Hickstein
  • , A. Muraro
  • , G. Roberts
  • , M. Worm
  • , M. B. Bilò
  • , V. Cardona
  • , A. E.J. Dubois
  • , A. Dunn Galvin
  • , P. Eigenmann
  • , M. Fernandez-Rivas
  • , S. Halken
  • , G. Lack
  • , B. Niggemann
  • , A. F. Santos
  • , B. J. Vlieg-Boerstra
  • , Z. Q. Zolkipli
  • A. Sheikh
  • University of Edinburgh
  • Imperial College London
  • The Evidence Centre
  • Tampere University
  • Ludwig Maximilian University of Munich
  • University of Padua
  • Isle of Wight NHS Trust
  • University Hospital Southampton NHS Foundation Trust
  • University of Southampton
  • Charité – Universitätsmedizin Berlin
  • Ospedali Riuniti Azienda Ospedaliera Universitaria Foggia
  • Hospital Universitari Vall d'Hebron
  • University of Groningen
  • University of Geneva
  • Hospital Clínico San Carlos de Madrid
  • University of Southern Denmark
  • MRC & Asthma UK Centre in Allergic Mechanisms of Asthma
  • King's College London
  • University of Coimbra
  • Amsterdam University Medical Centers
  • Brigham and Women’s Hospital

Research output: Contribution to journalReview articlepeer-review

Abstract

Background Anaphylaxis is an acute, potentially fatal, multi-organ system, allergic reaction caused by the release of chemical mediators from mast cells and basophils. Uncertainty exists around epidemiological measures of incidence and prevalence, risk factors, risk of recurrence, and death due to anaphylaxis. This systematic review aimed to (1) understand and describe the epidemiology of anaphylaxis and (2) describe how these characteristics vary by person, place, and time. Methods Using a highly sensitive search strategy, we identified systematic reviews of epidemiological studies, descriptive and analytical epidemiological investigations, and studies involving analysis of routine data. Results Our searches identified a total of 5 843 potentially eligible studies, of which 49 satisfied our inclusion criteria. Of these, three were suitable for pooled estimates of prevalence. The incidence rates for all-cause anaphylaxis ranged from 1.5 to 7.9 per 100 000 person-years. These data indicated that an estimated 0.3% (95% CI 0.1-0.5) of the population experience anaphylaxis at some point in their lives. Food, drugs, stinging insects, and latex were the most commonly identified triggers. Conclusions Anaphylaxis is a common problem, affecting an estimated 1 in 300 of the European population at some time in their lives. Future research needs to focus on better understanding of the trends across Europe and identifying those most likely to experience fatal reactions.

Original languageEnglish
Pages (from-to)1353-1361
Number of pages9
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume68
Issue number11
DOIs
Publication statusPublished - Nov 2013

Keywords

  • anaphylaxis
  • epidemiology
  • incidence
  • prevalence
  • risk factors

Fingerprint

Dive into the research topics of 'The epidemiology of anaphylaxis in Europe: A systematic review'. Together they form a unique fingerprint.

Cite this